Advanced search
Publication Cover
Breast Cancer: Targets and Therapy Volume 16, 2024 - Issue
Submit an article Journal homepage
108
Views
0
CrossRef citations to date
0
Altmetric
CLINICAL TRIAL REPORT

Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial

Ying Chen1 Department of Breast Surgery, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, People’s Republic of China;2 Department of Breast Surgery, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, People’s Republic of ChinaView further author information
,
Wen-Xia Li1 Department of Breast Surgery, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, People’s Republic of China;2 Department of Breast Surgery, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, People’s Republic of ChinaView further author information
,
Jia-Hua Wu1 Department of Breast Surgery, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, People’s Republic of China;2 Department of Breast Surgery, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, People’s Republic of ChinaView further author information
,
Geng-Hang Chen2 Department of Breast Surgery, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, People’s Republic of ChinaView further author information
,
Chun-Min Yang1 Department of Breast Surgery, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, People’s Republic of China;2 Department of Breast Surgery, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, People’s Republic of ChinaView further author information
,
Hai Lu1 Department of Breast Surgery, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, People’s Republic of China;2 Department of Breast Surgery, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, People’s Republic of ChinaView further author information
,
Xi Wang3 Department of Breast Oncology, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of ChinaView further author information
,
Shu-Sen Wang4 Department of Medical Oncology, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of ChinaView further author information
,
Heng Huang5 Department of Breast Oncology, Lianjiang People’s Hospital, Lianjiang, People’s Republic of ChinaView further author information
,
Li Cai6 Department of Medical Oncology, The Affiliated Tumour Hospital of Harbin Medical University, Harbin, People’s Republic of ChinaView further author information
,
Li Zhao7 Department of Breast Oncology, Guangzhou First People Hospital, Guangzhou, People’s Republic of ChinaView further author information
,
Rou-Jun Peng8 Department of Integrated Therapy in Oncology, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of ChinaView further author information
,
Ying Lin9 Department of Breast Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People’s Republic of ChinaView further author information
,
Jun Tang3 Department of Breast Oncology, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of ChinaView further author information
,
Jian Zeng10 Department of Breast Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People’s Republic of ChinaView further author information
,
Le-Hong Zhang11 Department of Breast Oncology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of ChinaView further author information
,
Yong-Li Ke12 Department of Breast Oncology, General Hospital of PLA Guangzhou Military Area, Guangzhou, People’s Republic of ChinaView further author information
,
Xian-Ming Wang13 Department of Breast Oncology, Shenzhen Second People’s Hospital, Shenzhen, People’s Republic of ChinaView further author information
,
Xin-Mei Liu14 Department of Breast Oncology, Haikou People’s Hospital, Haikou, People’s Republic of ChinaView further author information
,
An-Qin Zhang15 Department of Breast Oncology, Maternal and Child Health Care Hospital of Guangdong Province, Guangzhou, People’s Republic of ChinaView further author information
,
Fei Xu4 Department of Medical Oncology, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0001-8543-6636View further author information
ORCID Icon,
Xi-Wen Bi4 Department of Medical Oncology, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of ChinaView further author information
,
Jia-Jia Huang4 Department of Medical Oncology, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of ChinaView further author information
,
Ji-Bin Li16 Department of Good Clinical Practice, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0001-7632-3648View further author information
ORCID Icon,
Dan-Mei Pang17 Department of Medical Oncology, Foshan First People’s Hospital, Foshan, People’s Republic of ChinaView further author information
,
Cong Xue4 Department of Medical Oncology, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-3558-8572View further author information
ORCID Icon,
Yan-Xia Shi4 Department of Medical Oncology, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of ChinaView further author information
,
Zhen-Yu He18 Department of Radiotherapy, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-1402-8963View further author information
ORCID Icon,
Huan-Xin Lin18 Department of Radiotherapy, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-0621-4486View further author information
ORCID Icon,
Xin An4 Department of Medical Oncology, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-0683-5511View further author information
ORCID Icon,
Wen Xia4 Department of Medical Oncology, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of ChinaView further author information
,
Ye Cao16 Department of Good Clinical Practice, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of ChinaView further author information
,
Ying Guo16 Department of Good Clinical Practice, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of ChinaView further author information
,
Ruo-Xi Hong4 Department of Medical Oncology, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of ChinaView further author information
,
Kui-Kui Jiang4 Department of Medical Oncology, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-4498-8404View further author information
ORCID Icon,
Yong-Yi Zhong4 Department of Medical Oncology, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of ChinaView further author information
,
Ge Zhang19 Law Sau Fai Institute for Advancing Translational Medicine in Bone and Joint Diseases (TMBJ), School of Chinese Medicine, Hong Kong Baptist University, Hong KongView further author information
,
Piyawan Tienchaiananda20 Division of Medical Oncology, Department of Medicine, Faculty of Medicine, Rangsit University, Rajavithi Hospital, Bangkok, ThailandView further author information
,
Masahiro Oikawa21 The Department of Breast Surgery, New-wa-kai Oikawa Hospital, Fukuoka, JapanView further author information
,
Zhong-Yu Yuan4 Department of Medical Oncology, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Qian-Jun Chen22 State Key Laboratory of Traditional Chinese Medicine Syndrome/Departments of Gynecologic Oncology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, People’s Republic of China;23 State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Pages 223-231 | Received 30 Nov 2023, Accepted 27 Mar 2024, Published online: 12 Apr 2024

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.